🇺🇸 FDA
Company

ADC

ADC Therapeutics SA

ADCT pharma USA

Quick answer

ADC is a pharma company (ADCT) headquartered in EPALINGES, V8, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Loncastuximab Tesirine

Relapsed Diffuse Large B-Cell Lymphoma

Phase 3 · small_molecule · active

1 trials project

Odronextamab

B-cell Non Hodgkin Lymphoma

Phase 3 · small_molecule · active

1 trials project

ADCT-301

Acute Myeloid Leukemia (AML)

Phase 2 · small_molecule · terminated

1 trials project

ADCT-602

Blasts 5 Percent or More of Bone Marrow Nucleated Cells

Phase 2 · mab · terminated

1 trials project

Camidanlumab Tesirine

Relapsed Hodgkin Lymphoma

Phase 2 · small_molecule · completed

1 trials project

Cyclophosphamide

Double-Expressor Lymphoma

Phase 2 · small_molecule · active

1 trials project

Epcoritamab

Large B-cell Lymphoma

Phase 2 · small_molecule · active

1 trials project

Loncastuximab Tesirine

Diffuse Large B-cell Lymphoma

Phase 2 · small_molecule · active

4 trials project

Loncastuximab Tesirine

Waldenstrom Macroglobulinemia

Phase 2 · small_molecule · active

1 trials project

Loncastuximab Tesirine

Relapsed or Refractory Large B-cell Lymphoma

Phase 2 · small_molecule · active

1 trials project

Loncastuximab Tesirine

Relapsed Follicular Lymphoma

Phase 2 · small_molecule · terminated

1 trials project

Loncastuximab tesirine

Diffuse Large B-Cell Lymphoma Refractory

Phase 2 · small_molecule · completed

1 trials project

Loncastuximab tesirine

Follicular Lymphoma

Phase 2 · small_molecule · active

1 trials project

Loncastuximab tesirine

Post-transplant Lymphoproliferative Disorder

Phase 2 · small_molecule · active

1 trials project

Loncastuximab tesirine 150 µg/Kg

Marginal Zone Lymphoma

Phase 2 · small_molecule · active

1 trials project

imvotamab

Non-Hodgkin Lymphoma

Phase 2 · small_molecule · terminated

1 trials project

ADCT-301

Head and Neck Cancer Squamous Cell Carcinoma

Phase 1 · small_molecule · terminated

1 trials project

ADCT-301

Acute Myeloid Leukemia

Phase 1 · small_molecule · terminated

1 trials project

ADCT-402

Non-Hodgkin Lymphoma

Phase 1 · small_molecule · completed

1 trials project

ADCT-402

Acute Lymphoblastic Leukemia

Phase 1 · small_molecule · terminated

1 trials project

ADCT-502

Breast Cancer

Phase 1 · small_molecule · terminated

1 trials project

ADCT-601

Advanced Solid Tumors

Phase 1 · small_molecule · terminated

2 trials project

ADCT-901

Advanced Solid Tumors

Phase 1 · small_molecule · completed

1 trials project

Camidanlumab tesirine

Hodgkin Lymphoma

Phase 1 · small_molecule · completed

1 trials

Drugs (1)

drug

loncastuximab tesirine-lpyl

ZYNLONTA

Patents (8)

patent

US 11976122

Anti-IL13Rα2 antibodies

Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11938192

Dosage regimes for the administration of an anti-CD19 ADC

Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11813335

Pyrrolobenzodiazepine-antibody conjugates

Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11702473

Site-specific antibody-drug conjugates

Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11690918

Pyrrolobenzodiazepine-anti-CD22 antibody conjugates

Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11596696

Combination therapy with an anti-CD25 antibody-drug conjugate

Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11426467

Dosage regimes for the administration of an anti-CD25 ADC

Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11384098

Pyrrolobenzodiazepine-antibody conjugates

Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)